Beranda › Kanker Tiroid › Pennsylvania
Uji klinis Kanker Tiroid di Pennsylvania
7 studi untuk Kanker Tiroid mencari peserta di lokasi di Pennsylvania.
Kota di Pennsylvania
Teks studi resmi (Bahasa Inggris)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- dan 7 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069DESTINY-PANTUMOUR04
- Research Site, Philadelphia
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- Children's Hospital of Philadelphia, Philadelphia
Menerima pesertaFase 2
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06458036Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- Children's Hospital of Philadelphia, Philadelphia
Menerima pesertaFase 2
Usia 2 hingga 99 · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT05783323APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Penn State Milton S. Hershey Medical Center, Hershey
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jun 2025 · NCT03175224Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery
- Thomas Jefferson University, Philadelphia
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2025 · NCT06918223Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
- Children's Hospital of Philadelphia, Philadelphia
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 12 Des 2024 · NCT05668962Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.